# PHLDB2

## Overview
PHLDB2 is a gene that encodes the protein pleckstrin homology-like domain family B member 2, which is involved in various cellular processes, including synaptic plasticity and cell motility. The protein is characterized by its pleckstrin homology (PH) domain, which facilitates interactions with membrane phosphoinositides, playing a crucial role in signal transduction and cytoskeletal dynamics (Song2022Legionella; Xie2019PIP3Phldb2). PHLDB2 is also known as LL5β and is implicated in the regulation of NMDA and AMPA receptor density, essential for synaptic stability and receptor trafficking (Xie2019PIP3Phldb2). Additionally, PHLDB2 is involved in microtubule stabilization, influencing cell migration and tissue development (Song2022Legionella). The protein's interactions with various cellular and pathogenic proteins highlight its significance in both normal physiological processes and disease states, including cancer and vascular dementia (Eom2011Functions; Chen2019Oncogenic).

## Structure
PHLDB2 encodes a protein that contains a pleckstrin homology (PH) domain, which is crucial for its function in membrane association and protein-protein interactions (Song2022Legionella; Xie2019PIP3Phldb2). This domain is highly sensitive to phosphoinositides such as PIP3 and PIP2, allowing PHLDB2 to interact with membrane phosphoinositides, which are important for signal transduction and cytoskeletal dynamics (Xie2019PIP3Phldb2). The protein also contains two predicted coiled-coil domains, which may contribute to its structural stability and interaction with other proteins (Xie2019PIP3Phldb2).

PHLDB2 is a plasma membrane-associated protein, and its subcellular localization can be altered by cleavage events, such as those mediated by the bacterial protease Lem8, which targets PHLDB2 for cleavage at specific sites (Song2022Legionella). The protein is 1253 amino acids long, and the cleavage site is located between the 1106th and 1119th residues (Song2022Legionella).

Post-translational modifications, such as phosphorylation, may occur, affecting the protein's function and interactions. Splice variant isoforms of PHLDB2 can result in structural diversity, potentially influencing its role in cellular processes (Eom2011Functions).

## Function
PHLDB2, or pleckstrin homology-like domain family B member 2, is a protein involved in various cellular processes, particularly in synaptic plasticity and cell motility. In the nervous system, PHLDB2 plays a crucial role in synaptic plasticity by regulating the density of NMDA and AMPA receptors and the turnover of PSD-95, a scaffolding protein essential for synaptic stability and receptor trafficking. It is involved in the binding between NMDA receptors and CaMKII, which is necessary for the stabilization and trafficking of NMDA receptors, and it helps localize PSD-95 in the spine head (Xie2019PIP3Phldb2).

PHLDB2 is also a PIP3-sensing molecule that mediates PI3K activity downstream of the trkB receptor, which is crucial for long-term potentiation (LTP), a process underlying learning and memory. Its absence results in impaired AMPA receptor insertion and reduced postsynaptic membrane-expressed NR1, indicating its role in receptor stabilization and synaptic protein trafficking (Xie2019PIP3Phldb2).

In terms of cell motility, PHLDB2 is involved in microtubule stabilization, which is important for cell migration. It interacts with phosphoinositides at the cell membrane, influencing cellular dynamics and tissue development (Song2022Legionella).

## Clinical Significance
PHLDB2 is implicated in various cancers, including head and neck squamous cell carcinoma (HNSCC), colorectal, gastric, and lung adenocarcinoma. In HNSCC, PHLDB2 is upregulated and associated with poor prognosis. It promotes epithelial-mesenchymal transition (EMT) and metastasis by enhancing MDM2-mediated degradation of E-cadherin. Silencing PHLDB2 impedes cancer cell migration and tumor growth, suggesting its role in immune escape and potential as a target to improve CD8+ T cell-mediated antitumor immunity and PD-1 immunotherapy efficacy (Li2024Depletion).

In gastric cancer, PHLDB2 expression is linked to poor overall survival. It is involved in the NOTCH3-PHLDB2-Akt signaling pathway, which is associated with reduced disease-specific survival. Targeting this pathway could enhance sensitivity to chemotherapeutic agents (Kang2021NOTCH3).

PHLDB2 also plays a role in colon cancer, where it is targeted by miR-29c-3p, a microRNA regulated by p53. Higher PHLDB2 expression correlates with poorer survival outcomes, and its overexpression can attenuate the inhibitory effects of miR-29c-3p on cancer cell invasion and migration (Chen2017p53).

In vascular dementia, intronic nucleotide variants in PHLDB2, such as rs951660, are associated with increased susceptibility, potentially through delayed gene expression and altered splicing (Eom2011Functions).

## Interactions
PHLDB2, also known as LL5β, is involved in various protein interactions that influence cellular processes. It interacts with the Legionella pneumophila effector protein Lem8, a cysteine protease that cleaves PHLDB2, leading to reduced cell migration. This interaction is facilitated by the regulatory protein 14-3-3ζ, which activates Lem8's protease activity, highlighting a mechanism by which L. pneumophila modulates host cell motility (Song2022Legionella).

PHLDB2 also plays a critical role in synaptic plasticity by interacting with NMDA and AMPA receptors. It is essential for the interaction between NMDA receptors and CaMKII, which is crucial for long-term potentiation (LTP) induction. PHLDB2 contributes to the accumulation of GluA2, a subunit of AMPA receptors, at the membrane surface of dendritic spines through PIP3 signaling (Xie2019PIP3Phldb2).

In the context of cancer, PHLDB2 interacts with MDM2, facilitating MDM2-mediated E-Cadherin degradation, which is associated with epithelial-mesenchymal transition (EMT) in colorectal cancer. This interaction suggests a role for PHLDB2 in cancer cell migration and invasion (Chen2019Oncogenic).


## References


[1. (Li2024Depletion) Hongyu Li, Ziyi Wang, Huiting Liang, Xiaoyong Liu, Haichao Liu, Zehang Zhuang, and Jinsong Hou. Depletion of phldb2 suppresses epithelial–mesenchymal transition and enhances anti-tumor immunity in head and neck squamous cell carcinoma. Biomolecules, 14(2):232, February 2024. URL: http://dx.doi.org/10.3390/biom14020232, doi:10.3390/biom14020232. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/biom14020232)

[2. (Song2022Legionella) Lei Song, Jingjing Luo, Hongou Wang, Dan Huang, Yunhao Tan, Yao Liu, Yingwu Wang, Kaiwen Yu, Yong Zhang, Xiaoyun Liu, Dan Li, and Zhao-Qing Luo. Legionella pneumophila regulates host cell motility by targeting phldb2 with a 14-3-3ζ-dependent protease effector. eLife, February 2022. URL: http://dx.doi.org/10.7554/elife.73220, doi:10.7554/elife.73220. This article has 15 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.7554/elife.73220)

[3. (Eom2011Functions) Sangmi Eom and Chaeyoung Lee. Functions of intronic nucleotide variants in the gene encoding pleckstrin homology like domain beta 2 (phldb2) on susceptibility to vascular dementia. The World Journal of Biological Psychiatry, 14(3):227–232, November 2011. URL: http://dx.doi.org/10.3109/15622975.2011.630407, doi:10.3109/15622975.2011.630407. This article has 7 citations.](https://doi.org/10.3109/15622975.2011.630407)

[4. (Chen2019Oncogenic) Geng Chen, Tong Zhou, Tantan Ma, Tingting Cao, and Zhenxiang Yu. Oncogenic effect of phldb2 is associated with epithelial–mesenchymal transition and e-cadherin regulation in colorectal cancer. Cancer Cell International, July 2019. URL: http://dx.doi.org/10.1186/s12935-019-0903-1, doi:10.1186/s12935-019-0903-1. This article has 13 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s12935-019-0903-1)

[5. (Chen2017p53) Geng Chen, Tong Zhou, Yang Li, Zhenxiang Yu, and Liankun Sun. P53 target mir-29c-3p suppresses colon cancer cell invasion and migration through inhibition of phldb2. Biochemical and Biophysical Research Communications, 487(1):90–95, May 2017. URL: http://dx.doi.org/10.1016/j.bbrc.2017.04.023, doi:10.1016/j.bbrc.2017.04.023. This article has 47 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.bbrc.2017.04.023)

[6. (Kang2021NOTCH3) Wei Kang, Jinglin Zhang, Tingting Huang, Yuhang Zhou, Chi Chun Wong, Ronald C. K. Chan, Yujuan Dong, Feng Wu, Bin Zhang, William K. K. Wu, Michael W. Y. Chan, Alfred S. L. Cheng, Jun Yu, Nathalie Wong, Kwok Wai Lo, and Ka Fai To. Notch3, a crucial target of mir-491-5p/mir-875-5p, promotes gastric carcinogenesis by upregulating phldb2 expression and activating akt pathway. Oncogene, 40(9):1578–1594, January 2021. URL: http://dx.doi.org/10.1038/s41388-020-01579-3, doi:10.1038/s41388-020-01579-3. This article has 22 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/s41388-020-01579-3)

[7. (Xie2019PIP3Phldb2) Min-Jue Xie, Yasuyuki Ishikawa, Hideshi Yagi, Tokuichi Iguchi, Yuichiro Oka, Kazuki Kuroda, Keiko Iwata, Hiroshi Kiyonari, Shinji Matsuda, Hideo Matsuzaki, Michisuke Yuzaki, Yugo Fukazawa, and Makoto Sato. Pip3-phldb2 is crucial for ltp regulating synaptic nmda and ampa receptor density and psd95 turnover. Scientific Reports, March 2019. URL: http://dx.doi.org/10.1038/s41598-019-40838-6, doi:10.1038/s41598-019-40838-6. This article has 11 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41598-019-40838-6)